The Multiple Myeloma Channel is supported with funding from AbbVie (Platinum), Sanofi (Gold), Legend Biotech (Bronze), and through an educational grant from Alexion Pharma GmbH.
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
COMy 2022 | Collaboration in the myeloma community
In this video, Kenneth Anderson, MD, Dana-Farber Cancer Institute, Boston, MA, briefly highlights the importance of meetings such as COMy 2022 in bringing the myeloma community together and allowing clinicians, researchers, and patients, to share the latest updates in the field. Dr Anderson also comments on the commitment in the community, the importance of working together, and the future impact of novel immunotherapies on the field. This interview took place at the 8th World Congress on Controversies in Multiple Myeloma (COMy) 2022, held in Paris, France.
